B-MoGen Biotechnologies Company Overview

B-MoGen Biotechnologies, Inc. is a genome engineering company that was established to address complex cell engineering challenges in order to accelerate the study of human diseases and the development of novel therapies. The B-MoGen team is equipped with proprietary tools and knowledge that have been developed into finely honed methods for efficient cellular engineering.  We utilize this unique expertise to provide three distinct services that address highly complex gene delivery and gene editing.

 

We offer a non-viral transposon-based gene delivery platform to support the T-Cell immunotherapy industry; we are the first company in the world to demonstrate genome engineering of the mitochondria genome; and we offer fee-for-service custom cell engineering of both cell lines and, uniquely, primary human lymphohematopoietic cells for cancer research, drug screening, and antibody validation.